Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Retrospective study of survival outcomes in patients with hereditary pathogenic and variants of unknown significance mutations in pancreatic adenocarcinoma.
Authors
Ching Ying Lin
Cedars Sinai Medical Center, Los Angeles, CA
Ching Ying Lin , Natalie Moshayedi , Shant Thomassian , Jun Gong , Arsen Osipov , Andrew Eugene Hendifar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Other
DOI
10.1200/JCO.2022.40.4_suppl.616
Abstract #
616
Poster Bd #
L10
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
DNA damage repair (DDR) germline mutations (GMs) in pancreatic ductal adenocarcinoma (PDAC): A mono-institutional retrospective study.
First Author: Maria Bensi
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Comparison of pancreatic cancer outcomes diagnosed in surveillance and the general population: A propensity score-matched analysis.
First Author: Derk C.F. Klatte
Poster
2022 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller